scholarly journals A fatal autopsy case of metformin-associated lactic acidosis and respiratory failure with proven high plasma metformin concentration

2021 ◽  
Vol 28 (6) ◽  
pp. 532-536
Author(s):  
Ryo Totsuka ◽  
Hidetaka Suzuki ◽  
Fumiko Aihara ◽  
Urara Sakurai ◽  
Kazuhiro Matsuo ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Ngan Lam ◽  
Gurbir Sekhon ◽  
Andrew A. House

A 43-year-old woman was brought to the hospital with severe metabolic acidosis (pH 6.56, bicarbonate 3 mmol/L, and lactate 18.4 mmol/L) and a serum creatinine of 162 μmol/L with a serum potassium of 7.8 mmol/L. A delayed diagnosis of metformin-associated lactic acidosis was made, and she was treated with tris-hydroxymethyl aminomethane (THAM) and renal replacement therapy (RRT). Following a complete recovery, she admitted to ingesting 180 tablets (90 grams) of metformin. Her peak serum metformin concentration was 170 μg/mL (therapeutic range 1-2 μg/mL). Our case demonstrates an intentional metformin overdose resulting in lactic acidosis in a nondiabetic patient who was successfully treated with THAM and RRT.


Renal Failure ◽  
2011 ◽  
Vol 33 (6) ◽  
pp. 622-625 ◽  
Author(s):  
Akira Mima ◽  
Fumihiko Shiota ◽  
Takeshi Matsubara ◽  
Noriyuki Iehara ◽  
Taro Akagi ◽  
...  

Nosotchu ◽  
1980 ◽  
Vol 2 (1) ◽  
pp. 28-32 ◽  
Author(s):  
Yukito Shinohara ◽  
Fumihito Yoshii

2020 ◽  
Vol 21 ◽  
Author(s):  
Mikio Wada ◽  
Akihiro Nagata ◽  
Atsushi Kawashima ◽  
Keizo Kagawa

Author(s):  
Tess Jacob ◽  
Renee Garrick ◽  
Michael D Goldberg

Summary Metformin is recommended as the first-line agent for the treatment of type 2 diabetes. Although this drug has a generally good safety profile, rare but potentially serious adverse effects may occur. Metformin-associated lactic acidosis, although very uncommon, carries a significant risk of mortality. The relationship between metformin accumulation and lactic acidosis is complex and is affected by the presence of comorbid conditions such as renal and hepatic disease. Plasma metformin levels do not reliably correlate with the severity of lactic acidosis. We present a case of inadvertent metformin overdose in a patient with both renal failure and hepatic cirrhosis, leading to two episodes of lactic acidosis and hypoglycemia. The patient was successfully treated with hemodialysis both times and did not develop any further lactic acidosis or hypoglycemia, after the identification of metformin tablets accidentally mixed in with his supply of sevelamer tablets. Early initiation of renal replacement therapy is key in decreasing lactic acidosis-associated mortality. Learning points: When a toxic ingestion is suspected, direct visualization of the patient’s pills is advised in order to rule out the possibility of patient- or pharmacist-related medication errors. Though sending a specimen for determination of the plasma metformin concentration is important when a metformin-treated patient with diabetes presents with lactic acidosis, complex relationships exist between metformin accumulation, hyperlactatemia and acidosis, and the drug may not always be the precipitating factor. Intermittent hemodialysis is recommended as the first-line treatment for metformin-associated lactic acidosis (MALA). An investigational delayed-release form of metformin with reduced systemic absorption may carry a lower risk for MALA in patients with renal insufficiency, in whom metformin therapy may presently be contraindicated.


2020 ◽  
Vol 48 (12) ◽  
pp. e1194-e1202
Author(s):  
Youssef Bennis ◽  
Sandra Bodeau ◽  
Benjamin Batteux ◽  
Valérie Gras-Champel ◽  
Kamel Masmoudi ◽  
...  

2021 ◽  
Vol 2 (5) ◽  
pp. 206-209
Author(s):  
Andrew Koons ◽  
Alexandra Amaducci ◽  
Kenneth Katz

Introduction: Metformin is a biguanide used to treat diabetes mellitus (DM). Metformin-associated lactic acidosis (MALA) carries a high mortality and can occur in patients with renal failure from drug bioaccumulation. Reversible vision loss is a highly unusual, rarely reported complication of MALA. We present a case of a patient whose serum metformin concentration was unusually high and associated with vision loss. Case Report: A 60-year-old woman presented to an outside hospital emergency department with acute vision loss after being found at home confused, somnolent, and hypoglycemic, having last being seen normal two days prior. She reported vomiting and diarrhea during that time and a recently treated urinary tract infection. The visual loss resolved with continuous renal replacement therapy. Conclusion: This novel case of a patient with Type II DM prescribed metformin and insulin who developed reversible vision loss while suffering from MALA highlights the potential for vision loss in association with MALA.


Sign in / Sign up

Export Citation Format

Share Document